Hyo Jin Eom
Overview
Explore the profile of Hyo Jin Eom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi M, Moon S, Eom H, Lim S, Kim Y, Nam S
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35804944
Gastric cancer (GC) has the highest occurrence and fourth-highest mortality rate of all cancers in Korea. Although survival rates are improving with the development of diagnosis and treatment methods, the...
2.
Beak M, Park S, Kim J, Eom H, Lee H, Kim Y, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406376
Ras homologous A (RHOA), a signal mediator and a GTPase, is known to be associated with the progression of gastric cancer (GC), which is the fourth most common cause of...
3.
Kim J, Park S, Lim S, Eom H, Balch C, Lee J, et al.
Pharmacogenomics J
. 2020 Feb;
20(4):601-612.
PMID: 32015453
Previously, we identified Ras homologous A (RHOA) as a major signaling hub in gastric cancer (GC), the third most common cause of cancer death in the world, prompting us to...
4.
Kim S, Cohen A, Cho S, Eom H
Appl Psychol Meas
. 2019 Feb;
43(2):95-112.
PMID: 30792558
A brief review of various information criteria is presented for the detection of differential item functioning (DIF) under item response theory (IRT). An illustration of using information criteria for model...
5.
Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015
Kim J, Eom H, Lim G, Park S, Lee J, Nam S, et al.
Br J Cancer
. 2019 Feb;
120(5):488-498.
PMID: 30792535
Background: Gastric cancer (GC) is a highly heterogeneous disease with few "targeted" therapeutic options. Previously, we demonstrated involvement of the transcription factor HNF4α in human GC tumours, and the developmental...